Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2014/04/09
-
Indian UGC (journal)
-
Refrences17
-
Citations10
-
Shiro Kimbara
-
Yutaka Fujiwara
-
Masanori Toyoda
-
Naoko Chayahara
-
Yoshinori Imamura
-
Naomi Kiyota
-
Toru Mukohara
-
Atsushi Fukunaga
-
Masahiro Oka
-
Chikako Nishigori
-
Hironobu Minami
Cite
Kimbara, Shiro, et al. “Rapid Improvement of Glucagonoma-Related Necrolytic Migratory Erythema With Octreotide”. Clinical Journal of Gastroenterology, vol. 7, no. 3, 2014, pp. 255-9, https://doi.org/10.1007/s12328-014-0471-9.
Kimbara, S., Fujiwara, Y., Toyoda, M., Chayahara, N., Imamura, Y., Kiyota, N., Mukohara, T., Fukunaga, A., Oka, M., Nishigori, C., & Minami, H. (2014). Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide. Clinical Journal of Gastroenterology, 7(3), 255-259. https://doi.org/10.1007/s12328-014-0471-9
Kimbara, Shiro, Yutaka Fujiwara, Masanori Toyoda, Naoko Chayahara, Yoshinori Imamura, Naomi Kiyota, Toru Mukohara, et al. “Rapid Improvement of Glucagonoma-Related Necrolytic Migratory Erythema With Octreotide”. Clinical Journal of Gastroenterology 7, no. 3 (2014): 255-59. https://doi.org/10.1007/s12328-014-0471-9.
Kimbara S, Fujiwara Y, Toyoda M, Chayahara N, Imamura Y, Kiyota N, et al. Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide. Clinical Journal of Gastroenterology. 2014;7(3):255-9.
Journal Category
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the digestive system
Gastroenterology
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| 10.1158/1078-0432.CCR-11-2105 | 2012 | |||
| 10.1016/S0140-6736(11)61742-X | 2011 | |||
| 10.1056/NEJMoa1009290 | New England Journal of Medicine |
| 2011 | |
| 10.1056/NEJMoa1003825 | New England Journal of Medicine |
| 2011 | |
| Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour | Clinical Endocrinology |
| 68 | 2011 |
Refrences Analysis
The category
Medicine: Medicine (General) 15
is the most frequently represented among the references in this article. It primarily includes studies from New England Journal of Medicine and European Journal of Endocrinology. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Multinuclear 1H/13C/15N chemical shift assignment of therapeutic octreotide acetate performed at natural abundance | Magnetic Resonance in Chemistry |
| 2024 | |
| Diagnosis and comprehensive treatment of a glucagonoma in a patient with residual intrahepatic metastases postoperatively: A case report and literature review | Oncology Letters |
| 2024 | |
Diabetes Mellitus Secondary to Endocrine Diseases: An Update of Diagnostic and Treatment Particularities | International Journal of Molecular Sciences |
| 5 | 2023 |
| Dermatology in the Diagnosis of Noncutaneous Malignancy | Dermatologic Clinics |
| 3 | 2019 |
| Glucagonoma and Glucagonoma Syndrome: One Center's Experience of Six Cases | Journal of Pancreatic Cancer |
| 7 | 2018 |
Citations Analysis
The category
Medicine: Medicine (General) 6
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Glucagonoma syndrome: a review and update on treatment and was published in 2016. The most recent citation comes from a 2024 study titled Diagnosis and comprehensive treatment of a glucagonoma in a patient with residual intrahepatic metastases postoperatively: A case report and literature review. This article reached its peak citation in 2017, with 3 citations. It has been cited in 9 different journals. Among related journals, the Oncology Letters cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.